Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (605016.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.25B
EV5.25B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
48.9
45.2
51.8
61.3
72.8
95.2
105.1
104.7
Revenue % Chg.
—
-7.4%
14.5%
18.4%
18.7%
30.8%
10.5%
0.1%
Cost of Revenue
30.5
27.9
34.2
38.1
48.9
68.7
71.9
72.3
Gross Profit
18.4
17.3
17.6
23.2
23.8
26.5
33.3
32.3
Gross Profit Margin
37.6%
38.3%
34.0%
37.9%
32.8%
27.8%
31.7%
30.9%
R&D Expenses
1.5
1.5
1.6
2.2
2.2
3.4
3.9
4.4
Selling, General, & Admin Expenses
4.0
3.8
3.8
5.4
3.8
4.7
5.1
3.5
Other Expenses
0.6
0.2
0.8
0.9
0.6
0.9
1.2
0.9
Operating Income
10.7
11.0
11.3
14.4
16.1
17.5
25.7
26.5
Operating Income Margin
21.9%
24.4%
21.8%
23.4%
22.2%
18.4%
24.4%
25.3%
Total Other Income/Expenses Net
0.4
-0.2
-0.3
-0.4
-0.1
-0.2
-0.5
-0.7
Income Before Tax
11.1
10.8
11.0
14.0
16.0
17.3
25.2
25.8
Income Before Tax Margin
22.8%
23.9%
21.3%
22.8%
22.0%
18.2%
24.0%
24.7%
Income Tax Expense
1.7
1.5
1.5
1.9
2.1
2.1
3.2
3.3
Net Income
9.4
9.3
9.5
12.1
13.9
15.2
22.0
22.5
Net Income Margin
19.3%
20.5%
18.4%
19.7%
19.1%
16.0%
20.9%
21.5%
Weighted Avg. Shares Out
113.4
133.2
132.5
186.5
185.4
162.5
177.4
177.9
EPS
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
EPS % Chg.
—
-16.3%
3.0%
-10.7%
18.2%
23.1%
32.8%
9.7%
Weighted Avg. Shares Out Dil
113.4
133.2
94.6
—
185.4
162.5
177.4
177.9
EPS Diluted
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Interest Income
0.5
0.1
0.1
0.1
0.1
0.2
0.6
—
Interest Expense
2.8
1.3
0.7
0.3
0.6
0.2
0.0
0.2
EBIT
8.9
9.6
10.5
13.7
15.5
17.4
25.8
25.6
EBIT Margin
18.2%
21.3%
20.2%
22.3%
21.3%
18.3%
24.5%
24.5%
Depreciation & Amortization
0.1
0.1
4.0
5.2
7.2
6.9
7.1
-1.0
EBITDA
9.0
9.7
14.5
18.9
22.7
24.3
32.9
24.6
EBITDA Margin
18.3%
21.5%
28.0%
30.8%
31.2%
25.6%
31.3%
23.5%